{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:14:32Z","timestamp":1778591672472,"version":"3.51.4"},"reference-count":22,"publisher":"Pleiades Publishing Ltd","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":57,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dokl Biochem Biophys"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>A novel trend in anticancer therapy is based on the combination of cytotoxic and metabolic drugs. Bach1 is a transcription factor activating glycolysis and increasing proliferation and metastatic potential in cancer cells. The cytotoxic effect was evaluated for a combination of rotenone, an inhibitor of mitochondrial respiration, and two different inhibitors of Bach1 transcription factor in the prostate cancer cell lines (PC3 and Du145) and colorectal cancer (HT-29 and HCT-116) in a kinetic mode. An enhancement of the cytotoxic action of the combination therapy was observed only for the prostate cancer cell lines PC3 and Du145. No enhancement of cytotoxicity of zinc porphyrin in the presence of rotenone was observed for the \u041d\u0421\u0422-116 line. The HT-29 line was not sensitive to either inhibitor or their combination with rotenone at 24 h incubation. According to the PCR results, HT-29 was the only line showing an extremely high activation of heme oxygenase 1 (HMOX1) in the presence of the Bach1 inhibitor, pointing to the highest level of the antioxidant defense in this cell line. The sensitivity of the prostate cancer cell lines to the combination therapy points to the significant differences in the metabolism between the prostate and colorectal cell lines.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1134\/s1607672925601817","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T19:19:15Z","timestamp":1774898355000},"page":"59-64","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Enhancement of Rotenone Cytotoxicity in the Presence of Bach1 Inhibitors"],"prefix":"10.1134","volume":"526","author":[{"given":"S. V.","family":"Nikulin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Olkhovik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. V.","family":"Razumovskaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. O.","family":"Silkina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. A.","family":"Zakhariants","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.\u00a0V.","family":"Klycheva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. A.","family":"Khairetdinova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. G.","family":"Gazaryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. M.","family":"Hushpulian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"137","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"key":"7804_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F. Bray","year":"2024","unstructured":"Bray, F., Laversanne, M., and Sung, H., Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, Cancer J. Clin., 2024, vol. 74, no. 3, pp. 229\u2013263.","journal-title":"Cancer J. Clin."},{"key":"7804_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40364-024-00570-4","volume":"12","author":"D. Hu","year":"2024","unstructured":"Hu, D., Zhang, Z., Luo, X., Li, S., Jiang, J., Zhang, J., Wu, Zh., Wang, Yi., Sun, M., Chen, X., Zhang, B., Xu,\u00a0X., Wang, Sh., Xu, Sh., Wang, Yu., Huang, W., and Xia, L., Transcription factor BACH1 in cancer: roles, mechanisms, and prospects for targeted therapy, Biomarker Res., 2024, vol. 12, no. 1, p. 21. https:\/\/doi.org\/10.1186\/s40364-024-00570-4","journal-title":"Biomarker Res."},{"key":"7804_CR3","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ccell.2020.06.001","volume":"38","author":"J.D. Hayes","year":"2020","unstructured":"Hayes, J.D., Dinkova-Kostova, A.T., and Tew, K.D., Oxidative stress in cancer, Cancer Cell, 2020, vol. 38, no. 2, pp. 167\u2013197. https:\/\/doi.org\/10.1016\/j.ccell.2020.06.001","journal-title":"Cancer Cell"},{"key":"7804_CR4","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41586-019-1005-x","volume":"568","author":"J. Lee","year":"2019","unstructured":"Lee, J., Yesilkanal, A.E., Wynne, J.P., Frankenberger, C., Liu, J., Yan, J., Elbaz, M., Rabe, D.C., Rustandy, F.D., Tiwari, P., Grossman, E.A., Hart, P.C., Kang, Ch., Sanderson, S.M., Andrade, J., Nomura, D.K., Bonini, M.G., Locasale, J.W., and Rosner, M.R., Effective breast cancer combination therapy targeting BACH1 and mitochondrial metabolism, Nature, 2019, vol. 568, no. 7751, pp. 254\u2013258. https:\/\/doi.org\/10.1038\/s41586-019-1005-x","journal-title":"Nature"},{"key":"7804_CR5","doi-asserted-by":"publisher","unstructured":"Klenja-Skudrinja, D., Ali, K.X., Walker, D., Higgins, M., Patel, A.Ah., Raj, D., Creelman, A., Mcdowall, Ch., Taylor, C., Wenta, T., Larsson, E., Wiel, C., Sayin, V.I., and De La Vega, L., Identification of a BACH1 lung cancer signature: A novel tool for understanding BACH1 biology and identifying new inhibitors, Redox Biol., 2025, vol. 85, p. 103789. https:\/\/doi.org\/10.1016\/j.redox.2025.103789","DOI":"10.1016\/j.redox.2025.103789"},{"key":"7804_CR6","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.cell.2019.06.020","volume":"178","author":"N.M. Anderson","year":"2019","unstructured":"Anderson, N.M. and Simon, M.C., BACH1 orchestrates lung cancer metastasis, Cell, 2019, vol. 178, no. 2, pp. 265\u2013267. https:\/\/doi.org\/10.1016\/j.cell.2019.06.020","journal-title":"Cell"},{"key":"7804_CR7","doi-asserted-by":"publisher","unstructured":"Wang, Ch., Zhang, L., Cao, M., Fu, Zh., Wang, H., Zhang, S., Zhu, K., Hou, Zh., Cui, J., Yue, P., Guo, H., and Zhang, T., Thioredoxin facilitates hepatocellular carcinoma stemness and metastasis by increasing BACH1 stability to activate the AKT\/mTOR pathway, FASEB J., 2023, vol. 37, no. 6, p. e22943. https:\/\/doi.org\/10.1096\/fj.202300050rr","DOI":"10.1096\/fj.202300050rr"},{"key":"7804_CR8","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.bbrc.2018.02.178","volume":"499","author":"G.-D. Zhu","year":"2018","unstructured":"Zhu, G.-D., Liu, F., Ouyang, Sh., Zhou, R., Jiang, F.-N., Zhang, B., and Liao, W.-J., BACH1 promotes the progression of human colorectal cancer through BACH1\/CXCR4 pathway, Biochem. Biophys. Res. Commun., 2018, vol. 499, no. 2, pp. 120\u2013127. https:\/\/doi.org\/10.1016\/j.bbrc.2018.02.178","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"7804_CR9","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1080\/21691401.2017.1374284","volume":"46","author":"N. Shajari","year":"2018","unstructured":"Shajari, N., Davudian, S., Kazemi, T., Mansoori, B., Salehi, Sh., Khaze Shahgoli, V., Shanehbandi, D., Mohammadi, A., Duijf, P.H.G., and Baradaran, B., Silencing of BACH1 inhibits invasion and migration of prostate cancer cells by altering metastasis-related gene expression, Artif. Cells, Nanomed., Biotechnol., 2018, vol. 46, no. 7, pp. 1495\u20131504. https:\/\/doi.org\/10.1080\/21691401.2017.1374284","journal-title":"Artif. Cells, Nanomed., Biotechnol."},{"key":"7804_CR10","doi-asserted-by":"publisher","first-page":"634","DOI":"10.3390\/cells10030634","volume":"10","author":"J. Padilla","year":"2021","unstructured":"Padilla, J. and Lee, J., A novel therapeutic target, BACH1, regulates cancer metabolism, Cells, 2021, vol.\u00a010, no. 3, p. 634. https:\/\/doi.org\/10.3390\/cells10030634","journal-title":"Cells"},{"key":"7804_CR11","doi-asserted-by":"publisher","first-page":"6962","DOI":"10.1128\/mcb.02415-06","volume":"27","author":"Yu. Zenke-Kawasaki","year":"2007","unstructured":"Zenke-Kawasaki, Yu., Dohi, Yo., Katoh, Ya., Ikura, T., Ikura, M., Asahara, T., Tokunaga, F., Iwai, K., and Igarashi, K., Heme induces ubiquitination and degradation of the transcription factor Bach1, Mol. Cell. Biol., 2007, vol. 27, no. 19, pp. 6962\u20136971. https:\/\/doi.org\/10.1128\/mcb.02415-06","journal-title":"Mol. Cell. Biol."},{"key":"7804_CR12","doi-asserted-by":"publisher","unstructured":"Attucks, O.C., Jasmer, K.J., Hannink, M., Kassis, J., Zhong, Zh., Gupta, S., Victory, S.F., Guzel, M., Polisetti, D.R., Andrews, R., Mjalli, A.M.M., and Kostura, M.J., Induction of heme oxygenase I (HMOX1) by HPP-4382: a novel modulator of Bach1 activity, PLoS One, 2014, vol. 9, no. 7, p. e101044. https:\/\/doi.org\/10.1371\/journal.pone.0101044","DOI":"10.1371\/journal.pone.0101044"},{"key":"7804_CR13","doi-asserted-by":"publisher","unstructured":"Hushpulian, D.M., Kaidery, N.A., Soni, P., Poloznikov, A.A., Zakhariants, A.A., Razumovskaya, A.V., Silkina, M.O., Tishkov, V.I., Kazakov, E.H., Brown, A.M., Gaisina, I.N., Ahn, Y.-H., Kazakov, S.V., Krucher, N., Sharma, S.M., Paul, B.D., Gazaryan, I.G., Nikulin,\u00a0S.V., and Thomas, B., Functional analysis of bipartite NRF2 activators that overcome feedback regulation for age-related chronic diseases, Redox Biol., 2025, vol.\u00a086, p. 103794. https:\/\/doi.org\/10.1016\/j.redox.2025.103794","DOI":"10.1016\/j.redox.2025.103794"},{"key":"7804_CR14","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.bbagrm.2008.01.006","volume":"1779","author":"W. Hou","year":"2008","unstructured":"Hou, W., Shan, Yi., Zheng, J., Lambrecht, R.W., Donohue, S.E., and Bonkovsky, H.L., Zinc mesoporphyrin induces rapid and marked degradation of the transcription factor bach1 and up-regulates HO-1, Biochim. Biophys. Acta, Gene Regul. Mech., 2008, vol. 1779, no. 3, pp. 195\u2013203. https:\/\/doi.org\/10.1016\/j.bbagrm.2008.01.006","journal-title":"Biochim. Biophys. Acta, Gene Regul. Mech."},{"key":"7804_CR15","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1007\/s10495-025-02183-0","volume":"30","author":"Yu. Wang","year":"2025","unstructured":"Wang, Yu., Yang, Ch., Guo, L., Nie, P., Hu, X., Zhou, H., Li, H., Tao, H., and Wu, J., Targeting BACH1 by HPPE inhibits the Wnt\/\u03b2-catenin pathway and malignant phenotype in glioblastoma cells, Apoptosis, 2025, vol. 30, nos. 11\u201312, pp. 2848\u20132867. https:\/\/doi.org\/10.1007\/s10495-025-02183-0","journal-title":"Apoptosis"},{"key":"7804_CR16","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1007\/s00432-022-04371-w","volume":"149","author":"A.-M.K. Beier","year":"2023","unstructured":"Beier, A.-M.K., Puhr, M., Stope, M.B., Thomas, Ch., and Erb, H.H.H., Metabolic changes during prostate cancer development and progression, J. Cancer Res. Clin. Oncol., 2023, vol. 149, no. 5, pp. 2259\u20132270. https:\/\/doi.org\/10.1007\/s00432-022-04371-w","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"7804_CR17","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.biopha.2016.09.021","volume":"84","author":"S. Davudian","year":"2016","unstructured":"Davudian, S., Shajari, N., Kazemi, T., Mansoori, B., Salehi, Sh., Mohammadi, A., Shanehbandi, D., Shahgoli, V.Kh., Asadi, M., and Baradaran, B., BACH1 silencing by siRNA inhibits migration of HT-29 colon cancer cells through reduction of metastasis-related genes, Biomed. Pharmacother., 2016, vol. 84, pp. 191\u2013198. https:\/\/doi.org\/10.1016\/j.biopha.2016.09.021","journal-title":"Biomed. Pharmacother."},{"key":"7804_CR18","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.biopha.2017.01.030","volume":"88","author":"M. Aletaha","year":"2017","unstructured":"Aletaha, M., Mansoori, B., Mohammadi, A., Fazeli, M., and Baradaran, B., Therapeutic effects of bach1 siRNA on human breast adenocarcinoma cell line, Biomed. Pharmacother., 2017, vol. 88, pp. 34\u201342. https:\/\/doi.org\/10.1016\/j.biopha.2017.01.030","journal-title":"Biomed. Pharmacother."},{"key":"7804_CR19","first-page":"111","volume":"2","author":"X. Wu","year":"2014","unstructured":"Wu, X., Daniels, G., and Lee, P., Lipid metabolism in prostate cancer, Am. J. Clin. Exp. Urol., 2014, vol. 2, no.\u00a02, pp. 111\u2013120.","journal-title":"Am. J. Clin. Exp. Urol."},{"key":"7804_CR20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3389\/fonc.2017.00131","volume":"7","author":"E. Eidelman","year":"2017","unstructured":"Eidelman, E., Twum-Ampofo, J., Ansari, J., and Siddiqui, M.M., The metabolic phenotype of prostate cancer, Front. Oncol., 2017, vol. 7, p. 131. https:\/\/doi.org\/10.3389\/fonc.2017.00131","journal-title":"Front. Oncol."},{"key":"7804_CR21","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1038\/s41388-021-01667-y","volume":"40","author":"Yo. Ma","year":"2021","unstructured":"Ma, Yo., Zha, J., Yang, X., Li, Q., Zhang, Q., Yin, A., Beharry, Z., Huang, H., Huang, J., Bartlett, M., Ye,\u00a0K., Yin, H., and Cai, H., Long-chain fatty acyl-CoA synthetase 1 promotes prostate cancer progression by elevation of lipogenesis and fatty acid beta-oxidation, Oncogene, 2021, vol. 40, no. 10, pp. 1806\u20131820. https:\/\/doi.org\/10.1038\/s41388-021-01667-y","journal-title":"Oncogene"},{"key":"7804_CR22","doi-asserted-by":"publisher","first-page":"9132","DOI":"10.3390\/ijms26189132","volume":"26","author":"P. Parupathi","year":"2025","unstructured":"Parupathi, P., Devarakonda, L.S., Francois, E., Amjed, M., and Kumar, A., Reprogrammed lipid metabolism-associated therapeutic vulnerabilities in prostate cancer, Int. J. Mol. Sci., 2025, vol. 26, no. 18, p. 9132. https:\/\/doi.org\/10.3390\/ijms26189132","journal-title":"Int. J. Mol. Sci."}],"container-title":["Doklady Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S1607672925601817.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1134\/S1607672925601817","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S1607672925601817.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:49:25Z","timestamp":1778590165000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1134\/S1607672925601817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["7804"],"URL":"https:\/\/doi.org\/10.1134\/s1607672925601817","relation":{},"ISSN":["1607-6729","1608-3091"],"issn-type":[{"value":"1607-6729","type":"print"},{"value":"1608-3091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"15 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This work does not contain any studies involving human and animal subjects.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"ETHICS APPROVAL AND CONSENT TO PARTICIPATE"}},{"value":"The authors of this work declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"CONFLICT OF INTEREST"}}]}}